secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0001193805-23-000595
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus Therapeutics enters $50M revolving credit facility with Wells Fargo
----------------------------------------------------------------------------

- Credit agreement with Wells Fargo for $50M revolving line; two-year term, renewable annually.
- Borrowings bear interest at SOFR +1.00%; default rate +2.00%.
- No prepayment penalty; collateral of $55M in cash pledged.
- Commitment fee of 0.25% of loan amount for each renewal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380523000595/0001193805-23-000595-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380523000595/e618524_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-23-000595

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer